dacarbazine has been researched along with Ependymoma in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Benvenuto, J; Farquhar, D | 1 |
Aldape, K; Armstrong, TS; Gerstner, ER; Gilbert, MR; Lieberman, F; Mendoza, T; Mikkelsen, T; Omuro, A; Robins, HI; Vera, E; Wen, PY; Wu, J; Yuan, Y | 1 |
Bellu, L; Della Puppa, A; Gardiman, MP; Lombardi, G; Pambuku, A; Pomerri, F; Rumanò, L; Zagonel, V | 1 |
Arena, V; Binda, E; Lamorte, G; Meco, D; Riccardi, R; Servidei, T | 1 |
Fujihara, I; Fukuoka, K; Ichimura, K; Komori, K; Miyairi, Y; Morita, D; Nakamura, T; Ogiso, Y; Sakashita, K; Sano, K; Shigeta, H; Shiohara, M; Shirahata, M; Yanagisawa, R | 1 |
Bosa, C; Cassoni, P; Fiano, V; Franchino, F; Magistrello, M; Pellerino, A; Rudà, R; Soffietti, R; Trevisan, M | 1 |
Felsberg, J; Gramatzki, D; Hentschel, B; Hofer, S; Krex, D; Reifenberger, G; Roth, P; Rushing, EJ; Schnell, O; Simon, M; Weller, M; Westphal, M; Wick, W | 1 |
Chamberlain, MC; Johnston, SK | 1 |
Freyschlag, CF; Lohr, F; Schmieder, K; Seiz, M; Thomé, C; Tuettenberg, J | 1 |
Salameire, D | 1 |
Goto, Y; Hashimoto, N; Kagawa, N; Khoo, HM; Kinoshita, M; Kishima, H; Maruno, M; Yoshimine, T | 1 |
Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ | 1 |
Calvet, D; Delattre, JY; Janoray, P; Rojas-Marcos, I | 1 |
Brock, C; Newlands, ES; Rehman, S | 1 |
Bernstein, M; Fort, D; Friedman, H; Harris, MB; Kadota, R; Krailo, M; Kretschmar, CS; Mazewski, C; Nicholson, HS; Reaman, GH; Sato, J; Tedeschi-Blok, N | 1 |
Beal, DD; Bryan, GT; Cohen, SM; Croft, WA; Skibba, JL | 1 |
Bruce-Gregorios, JH; Feun, LG; Green, B; Nadeem, SQ | 1 |
2 trial(s) available for dacarbazine and Ependymoma
Article | Year |
---|---|
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
Topics: Adolescent; Adult; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Humans; Lapatinib; Prospective Studies; Spinal Cord Neoplasms; Temozolomide | 2021 |
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Ependymoma; Female; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Temozolomide; Treatment Outcome | 2007 |
15 other study(ies) available for dacarbazine and Ependymoma
Article | Year |
---|---|
1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Drug Evaluation, Preclinical; Ependymoma; Leukemia L1210; Melanoma; Mice; Mice, Inbred Strains; Structure-Activity Relationship | 1984 |
Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Cisplatin; Dacarbazine; Drug Therapy, Combination; Ependymoma; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radiography; Temozolomide; Treatment Outcome | 2013 |
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.
Topics: Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Disease Models, Animal; DNA Modification Methylases; Drug Resistance, Neoplasm; Ependymoma; Glioblastoma; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Stem Cells; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Temozolomide Treatment for Pediatric Refractory Anaplastic Ependymoma with Low MGMT Protein Expression.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Ependymoma; Female; Humans; Immunohistochemistry; Infant; Male; Temozolomide; Tumor Suppressor Proteins | 2016 |
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Ependymoma; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Temozolomide; Young Adult | 2016 |
Chemotherapy for intracranial ependymoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Epirubicin; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Procarbazine; Temozolomide; Treatment Outcome; Vincristine | 2016 |
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Ependymoma; Female; Ferrous Compounds; Humans; Male; Metallocenes; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Supratentorial Neoplasms; Temozolomide | 2009 |
Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Disease Progression; Ependymoma; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Recurrence; Supratentorial Neoplasms; Temozolomide; Treatment Outcome | 2011 |
[Cutaneous neutrophils infiltrates. Case 4. Pseudo-tumoral cutaneous alternariosis].
Topics: Aged, 80 and over; Alternaria; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma, Verrucous; Combined Modality Therapy; Dacarbazine; Dermatomycoses; Diagnosis, Differential; Ependymoma; Fatal Outcome; Folliculitis; Frontal Lobe; Hand Dermatoses; Humans; Immunocompromised Host; Keratosis; Male; Neutrophils; Pyrimidines; Skin Neoplasms; Staining and Labeling; Temozolomide; Triazoles; Voriconazole | 2011 |
Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide | 2013 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carboplatin; Carmustine; Dacarbazine; Disease Progression; Dose Fractionation, Radiation; Ependymoma; Gadolinium; Headache; Humans; Isotretinoin; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Remission Induction; Tamoxifen; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasm Recurrence, Local; Temozolomide; Time Factors | 2006 |
Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
Topics: Adenofibroma; Administration, Oral; Animals; Aza Compounds; Carcinogens; Dacarbazine; Dose-Response Relationship, Drug; Ependymoma; Female; Hypoxanthines; Injections, Intraperitoneal; Intubation, Gastrointestinal; Leiomyosarcoma; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Organ Specificity; Rats; Stomach Neoplasms; Thymus Neoplasms; Time Factors; Triazenes; Urinary Bladder Neoplasms; Uterine Neoplasms | 1975 |
Post radiation sarcoma (malignant fibrous histiocytoma) of the cervical spine following ependymoma (a case report).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cervical Vertebrae; Combined Modality Therapy; Dacarbazine; Dexamethasone; Diagnostic Errors; Doxorubicin; Ependymoma; Histiocytoma, Benign Fibrous; Humans; Laminectomy; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, High-Energy; Spinal Cord Neoplasms; Spinal Neoplasms | 1991 |